The lead investigator from the REDUCE trial discusses his perspective on how these patients should be approached.
A Q&A with Scott Kasner, MD
The field of neurotoxins has grown recently, but how do the agents compare? Here’s a closer look at the therapies available on the US market.
By Stephen Gollomp, MD
Ancient scholars and contemporary authors can provide insights on the experiences of patients with migraine and our treatment of them.
By Randolph W. Evans, MD
By Paul Winnington, Editorial Director
New findings suggest a novel in-office imaging technique can help identify MS patients who are likely to have increased disease severity. An investigator explains.
A Q&A with Shiv Saidha, MBBCh, MRCPI
Painless and low-cost, neuromuscular ultrasound can be an important adjuvant to clinical and electrodiagnostic findings in the evaluation of peripheral neuropathies.